From her first days in the patent profession, Claire has been involved with many of the major innovations in the life sciences’ field. These have spanned immunology-related therapeutics, RNA therapeutics, synthetic biology and genetic diagnostics, including applications of bioinformatics. This continues as a partner of both the specialist HGF CRISPR and microbiome IP teams.
Claire has extensive experience of opposition and appeal proceedings at the European Patent Office, including both defending and opposing high profile patents which have attracted much interest beyond patent professionals. This has included patents from the early days of recombinant antibodies through to controversial patents arising from gene discovery and more recently, much publicised patents for gene-editing technologies.
Claire also has much experience of handling patent portfolios demanding inter-disciplinary input including in the fields of bioinformatics and medical and diagnostic devices. This has included much in the application of high-throughput nucleic acid sequencing technologies such as non-invasive foetal testing and cancer diagnostics.
As one of the most experienced patent partners’ of the life science team, Claire has the reputation of being able to apply creative thinking to turn around the most difficult IP problems. She has been responsible for building the IP portfolios of a number of companies and continues to enjoy the challenge of advising on freedom-to-operate and IP strategy.
MA(Oxon) Biochemistry with supplemental chemical pharmacology
PhD St George's Hospital Medical School
Accompanying quotes: a " fearless warrior"; "Claire pays meticulous attention to detail and has superb technical and scientific knowledge; clients can concentrate on their own growth knowing their IP is in safe hands."
HGF is sponsoring The Business of Science Conference 2021 on 7th October. Science and the commercialisation of science continues to be fundamental to the economic growth of the UK and …Event details
IAM Strategy 300 Global Leaders guide has been published and HGF is delighted to have 4 Partners listed. The guide draws from the worlds of private practice, consulting and other …Read article
HGF’s Partner Dr Markus Zoller is attending and speaking at the German Biotechnology days on 20th September 2021. German Biotechnology days is the go to event in the industry and …Event details
HGF is sponsoring the Autonomous Vehicles Expo which is being held on 9th September. Autonomous Vehicles Expo will provide key insights from industry experts on how disruptive technological advances will …Event details
Oral proceedings by videoconference can be enforced by the EPO during the pandemic On 16 July 2021 the EPO’s Enlarged Board of Appeal (EBoA) decided on referral G 1/21 regarding …Read article
HGF in Europe and Shiga in Japan are holding a joint webinar on 29th July 2021. Fitter, faster, stronger – patenting sports and fitness technology in Europe and Japan Sporting …Event details
The IAM Patent 1000 – the world’s leading patent professionals 2021 guide has now been published. HGF has 18 European attorneys listed. IAM Patent 1000 is a unique guide that …Read article
WIPR Patents Live is holding a complimentary session on July 20, at 5pm BST/12pm ET, where HGF Partner & Patent Attorney Kieran Killough will present on ‘Protecting medical devices in …Event details
If you would like to discuss how HGF could help you, contact one of our IP specialists.